翔宇医疗收盘上涨2.12%，滚动市盈率69.11倍，总市值60.00亿元

Company Overview - Xiangyu Medical focuses on the research, production, and sales of rehabilitation medical devices, offering a wide range of products across 10 categories and over 1,000 items [2] - The company has received multiple awards for its projects, including first prizes from the Chinese Rehabilitation Medicine Association and various provincial awards for technological advancements in rehabilitation [2] Financial Performance - For Q1 2025, the company reported a revenue of 186 million yuan, representing a year-on-year increase of 10.02%, while net profit was 22.95 million yuan, showing a decline of 41.26% [3] - The gross profit margin stood at 65.30% [3] Market Position - As of May 29, the company's stock closed at 37.5 yuan, with a rolling price-to-earnings (PE) ratio of 69.11, significantly higher than the industry average of 49.64 and the median of 36.36 [1][3] - The total market capitalization of Xiangyu Medical is 6 billion yuan [1] Institutional Holdings - By the end of Q1 2025, 16 institutions held shares in Xiangyu Medical, including 10 funds, with a total holding of approximately 111.63 million shares valued at 406.3 million yuan [1]